Targeted oncogenes such as EGFR, Bcl-2, and KRAS, which are frequently overexpressed in various cancers, have been successfully silenced using siRNA-based approaches, demonstrating enhanced tumor suppression and chemosensitization [184]. The gene discussed is BCL2; the disease is neoplasm.